Current through Register Vol. 50, No. 9, September 20, 2024
A. Notwithstanding
§6505. E of this
Subchapter, a registrant may dispense up to a single 48 hour supply of a single
controlled substance or drug of concern to a patient.
B. The prohibition contained in
§6505. E of this
Subchapter shall not apply to a registrant:
1. practicing in a facility maintained or
operated by the state of Louisiana or a governmental entity of this
state;
2. practicing in a clinic
maintained or operated by the United States or by any of its departments,
offices or agencies;
3. practicing
in a substance abuse or addiction treatment facility licensed by the Louisiana
Department of Health and Hospitals; or
4. engaged in clinical research or
investigational studies regulated by the U.S. Food and Drug Administration, in
compliance with all applicable state and federal laws, rules and
regulations.
C. Upon
written application by a physician to the board made in accordance with this
Subsection the board may, with respect to an identified individual patient:
1. authorize a physician to depart from the
dispensing limitation prescribed by
§6506. A of this
Subchapter. Such application shall contain:
a. a statement by the physician of the
specific manner in which the physician proposes to deviate from the provisions
of this Subchapter respecting the dispensing limitation on controlled
substances and drugs of concern, together with a statement by the physician of
the medical facts and circumstances deemed by the physician to justify such
departure; and
b. such other
information and documentation as the board may request;
2. the board may deny, grant, or grant in
part any application for exception in an individual case made under this
Section. The board's action on any such application shall be stated in writing
and shall specify the manner and extent to which the physician shall be
authorized to depart from the provisions of
§6506. A of this
Subchapter and the period of time during which such authorized exception shall
be effective. A physician who makes application to the board under this Section
shall not deviate from the prohibitions, conditions, and limitations provided
in §6506.
A of this Subchapter except following receipt
of written authorization from the board or other than pursuant to the
specifications and limitations of such authorization.
D. Notwithstanding
§6505. E of this
Subchapter, a registrant may dispense up to a single seven day supply of a
non-narcotic, non-anorectic schedule V controlled substance for the purpose of
assessing a therapeutic response when prescribed according to indications
approved by the United States Food and Drug Administration and:
1. the medication is prepackaged by the
original manufacturer;
2. the
prepackaged medication is provided at no cost to a dispensing physician for
dispensation to a patient at no cost to the patient; and
3. the dispensing physician submits all
required information regarding each dispensation to the Louisiana Board of
Pharmacy in accordance with the Prescription Monitoring Program Act,
R.S.
40:1001 et seq.
AUTHORITY NOTE:
Promulgated in accordance with
R.S.
37:1261-1292 and
R.S.
37:1201.
